Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis-Reference-Cited by-同舟云学术

Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis

Published:2015-06-01 Issue:6 Volume:151 Page:616
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Menting Stef P.¹,Coussens Emma²,Pouw Mieke F.³,van den Reek Juul M. P. A.⁴,Temmerman Linda⁵,Boonen Hugo⁶,de Jong Elke M. G. J.⁴,Spuls Phyllis I.¹,Lambert Jo²

Affiliation:

1. Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

2. Department of Dermatology, Ghent University Hospital, Gent, Belgium

3. Jan van Breemen Research Institute/Reade, Amsterdam, the Netherlands4Sanquin Research and Landsteiner Laboratory, Department of Immunopathology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands

4. Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands

5. Department of Dermatology, Maria Middelares Hospital, Gent, Belgium

6. Department of Dermatology, H Hart Ziekenhuis, Mol, Belgium

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADALIMUMAB DRUG MONITORING AND TREATMENT ADJUSTMENT TO DRUG ANTIBODIES IN NON-INFECTIOUS UVEITIS;American Journal of Ophthalmology;2024-09

2. Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation;The AAPS Journal;2024-07-24

3. Ixekizumab trough concentrations in psoriasis: Paving the way towards personalised therapy: A cohort study;JEADV Clinical Practice;2024-07-04

4. Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis;Journal of the European Academy of Dermatology and Venereology;2024-05-08

5. Functional Genomics and Insights into the Pathogenesis and Treatment of Psoriasis;Biomolecules;2024-05-03